Cargando…
Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes
Introduction: Advanced glycation end products (AGEs) in diet and serum are positively correlated with chronic conditions such as type 2 diabetes and cognitive decline. Dietary reduction of AGEs was shown to reduce their level in serum and to have a beneficial effect on metabolic biomarkers. However,...
Autores principales: | Lotan, Roni, Ganmore, Ithamar, Livny, Abigail, Shelly, Shahar, Zacharia, Moran, Uribarri, Jaime, Beisswenger, Paul, Cai, Weijing, Schnaider Beeri, Michal, Troen, Aron M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917071/ https://www.ncbi.nlm.nih.gov/pubmed/33659267 http://dx.doi.org/10.3389/fnut.2021.614149 |
Ejemplares similares
-
Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT
por: Lotan, Roni, et al.
Publicado: (2020) -
Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults
por: Schnaider Beeri, Michal, et al.
Publicado: (2022) -
Publisher Correction: TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes
por: Ganmore, Ithamar, et al.
Publicado: (2020) -
TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes
por: Ganmore, Ithamar, et al.
Publicado: (2019) -
Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes
por: Lesman-Segev, Orit H., et al.
Publicado: (2023)